Jose Calle Gordo

Active Investor

Angel investor in Malaga

Malaga, Andalusia

Jose Calle Gordo, Angel investor in Malaga is an active investor based in Malaga, Andalusia. This profile covers what Jose Calle Gordo backs, at which stage, and how founders can reach out in 2026.

Mr. Jose Gordo serves as Chief Executive Officer and Managing Partner at Akilia Partners. He served as Board Member at FEops. He serves as Vice Chairman at Biosensors International Group He serves as Chairman at HighLife and Sahajanand Medical Technologies. Mr. Gordo served as a Board Member at JenaValve Technology and Paragate Medical. He also holds several board positions, Chairman at Anusar (Diagnostic of congestion in Heart Failure), and a Non-Exec board member at Paragate Medical (Fluid Management in Heart Failure). He has also recently been on the boards of Jenavalve, LungPacer, FEOPs, and Laminate Medical, representing Valiance Advisors as an Operating Partner. Before this, he served as CEO of Biosensors International, an interventional cardiology company. Previously, he held several leadership roles at Abbott Vascular and Guidant, where Mr. Gordo led the commercialization of Mitraclip, for the treatment of mitral regurgitation, and the development and commercialization of the drug-eluting stent Xience program. He started his career at Eli Lilly, where he had a number of commercial roles with growing responsibility in the field of cardiac devices. He holds an electrical engineering degree (MSc) from the Universidad Politécnica de Madrid, Spain.

Investor type
Angel
Stages
Early Stage Venture
Invests in
Healthcare & BiotechDigital Health & HealthTechBiotech & PharmaMedTech & Medical DevicesSaaS & EnterpriseManufacturing & Industrial
Location
Malaga, Andalusia
Typical check
$500K
Past investments
7

Notable investments

HighLifeFEopsLaminate Medical Technologies Ltd.JenaValve Technology, Inc.Lungpacer Medical Inc.Biosensors International Group, LtdParagate Medical

How to reach Jose Calle Gordo

Angels and operators like Jose Calle Gordo reply to specific, personalized notes that show real traction, not mass blasts. Build a verified list, write a note that fits their thesis, and track replies, all on Round Funded.

Reach active investors like this one

Application closes in --:--:--
Get investor contacts

About this profile

This profile is part of Round Funded, an investor database and outreach platform for founders. It covers 60,000+ active VCs, angels, family offices and accelerators with verified contacts, lets you send pitches from your own Gmail, and includes a free Data Room for your raise. How this data is built.

Cite this page

Round Funded. "Jose Calle Gordo." Round Funded investor database, updated September 8, 2026.

Stable URL, it will not change: https://www.roundfunded.com/en/investor/jose-calle-gordo

Frequently Asked Questions

What does Jose Calle Gordo invest in?

Jose Calle Gordo invests in Healthcare & Biotech, Digital Health & HealthTech, Biotech & Pharma and MedTech & Medical Devices, typically at Early Stage Venture. Match your sector and stage, then reach out with a personalized pitch.

What stage does Jose Calle Gordo invest at?

Jose Calle Gordo typically invests at Early Stage Venture. Lead with traction that fits the stage when you reach out.

What is Jose Calle Gordo's typical check size?

Jose Calle Gordo typically writes checks around $500K. Use it as a signal for whether your raise fits their stage.

How do founders reach investors like this?

Round Funded lists active investors with verified, professional contact details for signed-up founders. Filter by sector, stage and location, then send a personalized pitch from your own inbox.

What is Round Funded?

Round Funded is an investor database and outreach platform for startup founders. It lists 60,000+ active investors with verified contacts, filtered to recent investment activity, and lets founders send personalized pitches from their own Gmail, track replies, and share a free Data Room. Round+ starts at $99 per month with a 3-day trial.

Application closes in --:--:--
Get investor contacts